Aigen Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-4,509
Closed -$1.18M – 952
2025
Q2
$1.18M Buy
+4,509
New +$1.1M 0.16% 202
2023
Q4
– Sell
-2,315
Closed -$465K – 940
2023
Q3
$465K Sell
2,315
-494
-18% -$104K 0.09% 384
2023
Q2
$582K Buy
+2,809
New +$545K 0.09% 308
2022
Q2
– Sell
-13,907
Closed -$3.15M – 641
2022
Q1
$3.15M Buy
13,907
+9,930
+250% +$2.34M 0.54% 44
2021
Q4
$1.02M Buy
+3,977
New +$985K 0.06% 415
2020
Q2
– Sell
-3,987
Closed -$433K – 1081
2020
Q1
$433K Sell
3,987
-3,379
-46% -$487K 0.06% 466
2019
Q4
$1.07M Buy
+7,366
New +$1.06M 0.18% 166

Other funds holding LH

Aigen Investment Management's LH Position: Q3 2025 in Review

Aigen Investment Management sold out of Labcorp (LH) in Q3 2025, closing a stake of 4,509 shares — an estimated $1.18M sold.

Aigen Investment Management first reported a position in LH in Q4 2019 and held it in 7 quarters. The position peaked at $3.15M in Q1 2022. 1,012 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Aigen Investment Management reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Aigen Investment Management sold 4,509 Labcorp shares in Q3 2025, an estimated $1.18M.
  • Aigen Investment Management first reported a position in Labcorp in Q4 2019 and held it in 7 quarters.
  • Aigen Investment Management's Labcorp position peaked at $3.15M in Q1 2022.
  • 1,012 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Aigen Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.